Reactive oxygen species and superoxide dismutases: role in joint diseases{lozenge, open}{lozenge, open}Pour citer cet article, utiliser ce titre en anglais et sa référence dans le même volume de Joint Bone Spine.;Radicaux libres dérivés de l'oxygène et superoxydes dismutases : rôle dans les maladies rhumatismales

Revue du Rhumatisme (Edition Francaise)

Volumn 74, Issue 7, 2007, Pages 636-643

  Afonso, Valéry ^a   Champy, Romuald ^a   Mitrovic, Dragoslav ^a   Collin, Pascal ^a   Lomri, Abderrahim ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Arthritis; Crystal induced arthropathies; Reactive oxygen species; Rheumatoid arthritis; SOD mimetics; Superoxide anion; Superoxide dismutase

Indexed keywords

EID: 34447341719     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rhum.2006.12.009     Document Type: Short Survey

References (50)

1. Halliwell B., Gutteridge J.M., and Cross C.E. Free radicals, antioxidants and human disease. Where are we now?. J. Lab. Clin. Med. 119 (1992) 598-620
2. Henrotin Y., Kurz B., and Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthritis Cartilage 13 (2005) 643-654
3. Henrotin Y.E., Bruckner P., and Pujol J.P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthritis Cartilage 11 (2003) 747-755
4. Sakurai H., Kohsaka H., Liu M.F., Higashiyama H., Hirata Y., Kanno K., et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J. Clin. Invest. 96 (1995) 2357-2363
5. Marklund S.L., Bjelle A., and Elmqvist L.G. Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann. Rheum. Dis. 45 (1986) 847-851
6. Sandhu J.K., Robertson S., Birnboim H.C., and Goldstein R. Distribution of protein nitrotyrosine in synovial tissues of patients with rheumatoid arthritis and osteoarthritis. J. Rheumatol. 30 (2003) 1173-1181
7. Mathy-Hartert M., Martin G., Devel P., Deby-Dupont G., Pujol J.P., Reginster J.Y., et al. Reactive oxygen species downregulate the expression of pro-inflammatory genes by human chondrocytes. Inflamm. Res. 52 (2003) 111-118
8. Goebel K.M., Storck U., and Neurath F. Intrasynovial orgotein therapy in rheumatoid arthritis. Lancet 1 (1981) 1015-1017
9. Ross A.D., Banda N.K., Muggli M., and Arend W.P. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase. Arthritis Rheum. 50 (2004) 3702-3711
10. Iyama S., Okamoto T., Sato T., Yamauchi N., Sato Y., Sasaki K., et al. Treatment of murine collagen-induced arthritis by ex vivo extracellular superoxide dismutase gene transfer. Arthritis Rheum. 44 (2001) 2160-2167
11. Salvemini D., and Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit. Care Med. 31 Supp (2003) 29-38
12. Halliwell B., and Gutteridge J.M. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186 (1990) 1-85
13. Haddad J.J. Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors. Cell. Signal. 14 (2002) 879-897
14. Wiseman H., and Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313 (1996) 17-29
15. Bruckdorfer K.R. Lipid oxidation products and vascular function. Free Radic. Res. 28 (1998) 573-581
16. Tiku M.L., Gupta S., and Deshmukh D.R. Aggrecan degradation in chondrocytes is mediated by reactive oxygen species and protected by antioxidants. Free Radic. Res. 30 (1999) 395-405
17. Davies K.J. Protein damage and degradation by oxygen radicals. I. General aspects. J. Biol. Chem. 262 (1987) 9895-9901
18. Stadtman E.R. Oxidation of proteins by mixed-function oxidation systems: implication in protein turnover, aging and neutrophil function. Trends Biochem. Sci. 11 (1986) 11-12 (not n PubMED - perhaps replace by Biochem Biophys Res Commun 2005 338 432-6 ?? [same first author and much more recent])
19. Johnson F., and Giulivi C. Superoxide dismutases and their impact upon human health. Mol. Aspects Med. 26 (2005) 340-352
20. McCord J.M., and Edeas M.A. SOD, oxidative stress and human pathologies: a brief history and a future vision. Biomed. Pharmacother. 59 (2005) 139-142
21. Orr W.C., Mockett R.J., Benes J.J., and Sohal R.S. Effects of overexpression of copper-zinc and manganese superoxide dismutases, catalase, and thioredoxin reductase genes on longevity in Drosophila melanogaster. J. Biol. Chem. 278 (2003) 26418-26422
22. Fujimura M., Morita-Fujimura Y., Noshita N., Sugawara T., Kawase M., and Chan P.H. The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. J. Neurosci. 20 (2000) 2817-2824
23. Reaume A.G., Elliott J.L., Hoffman E.K., Kowall N.W., Ferrante R.J., Siwek D.F., et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat. Genet. 13 (1996) 43-47
24. Huang T.T., Yasunami M., Carlson E.J., Gillespie A.M., Reaume A.G., Hoffman E.K., et al. Superoxide-mediated cytotoxicity in superoxide dismutase-deficient fetal fibroblasts. Arch. Biochem. Biophys. 344 (1997) 424-432
25. Okado-Matsumoto A., and Fridovich I. Amyotrophic lateral sclerosis: a proposed mechanism. Proc. Natl. Acad. Sci. USA 99 (2002) 9010-9014
26. Afonso V., Santos G., Collin P., Khatib A.M., Mitrovic D., Lomri N., et al. TNF-α down-regulates human Cu/Zn superoxide dismutase 1 promoter via JNK/AP-1 signaling pathway. Free Radic. Biol. Med. 41 (2006) 709-721
27. Morten K.J., Ackrell B.A., and Melov S. Mitochondrial reactive oxygen species in mice lacking superoxide dismutase 2: attenuation via antioxidant treatment. J. Biol. Chem. 281 (2006) 3354-3359
28. Wheeler M.D., Nakagami M., Bradford B.U., Uesugi T., Mason R.P., Connor H.D., et al. Overexpression of manganese superoxide dismutase prevents alcohol-induced liver injury in the rat. J. Biol. Chem. 276 (2001) 36664-36672
29. Kiningham K.K., Xu Y., Daosukho C., Popova B., and St Clair D.K. Nuclear factor kappaB-dependent mechanisms coordinate the synergistic effect of PMA and cytokines on the induction of superoxide dismutase 2. Biochem. J. 353 (2001) 147-156
30. Marklund S.L. Human copper-containing superoxide dismutase of high molecular weight. Proc. Natl. Acad. Sci. USA 79 (1982) 7634-7638
31. Fattman C.L., Schaefer L.M., and Oury T.D. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35 (2003) 236-256
32. Enghild J.J., Thogersen I.B., Oury T.D., Valnickova Z., Hojrup P., and Crapo J.D. The heparin-binding domain of extracellular superoxide dismutase is proteolytically processed intracellularly during biosynthesis. J. Biol. Chem. 274 (1999) 14818-14822
33. Juul K., Tybjaerg-Hansen A., Marklund S., Heegaard N.H., Steffensen R., Sillesen H., et al. Genetically reduced antioxidative protection and increased ischemic heart disease risk: the Copenhagen City Heart Study. Circulation 109 (2004) 59-65
34. Martel-Pelletier J., Alaaeddine N., and Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front. Biosci. 4 (1999) 694-703
35. Yudoh K., Nguyen T., Nakamura H., Hongo-Masuko K., Kato T., and Nishioka K. Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res. Ther. 7 (2005) 380-391
36. Loeser R.F., Carlson C.S., Del Carlo M., and Cole A. Detection of nitrotyrosine in aging and osteoarthritic cartilage: Correlation of oxidative damage with the presence of interleukin-1beta and with chondrocyte resistance to insulin-like growth factor 1. Arthritis Rheum. 46 (2002) 2349-2357
37. Stralin P., and Marklund S.L. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151 (2000) 433-441
38. Adachi T., Toishi T., Takashima E., and Hara H. Infliximab neutralizes the suppressive effect of TNF-alpha on expression of extracellular-superoxide dismutase in vitro. Biol. Pharm. Bull. 29 (2006) 2095-2098
39. Terkeltaub R., Zachariae C., Santoro D., Martin J., Peveri P., and Matsushima K. Monocyte-derived neutrophil chemotactic factor/interleukin-8 is a potential mediator of crystal-induced inflammation. Arthritis Rheum. 34 (1991) 894-903
40. Liu-Bryan R., and Lioté F. Monosodium urate and calcium pyrophosphate dihydrate (CPPD) crystals, inflammation, and cellular signaling. Joint Bone Spine 72 (2005) 295-302
41. McCarty D.J., Lehr J.R., and Halverson P.B. Crystal populations in human synovial fluid. Identification of apatite, octacalcium phosphate, and tricalcium phosphate. Arthritis Rheum. 26 (1983) 1220-1224
42. Prudhommeaux F., Schiltz C., Lioté F., Hina A., Champy R., Bucki B., et al. Variation in the inflammatory properties of basic calcium phosphate crystals according to crystal type. Arthritis Rheum. 39 (1996) 1319-1326
43. Reuben P.M., Brogley M.A., Sun Y., and Cheung H.S. Molecular mechanism of the induction of metalloproteinases 1 and 3 in human fibroblasts by basic calcium phosphate crystals. Role of calcium-dependent protein kinase C alpha. J. Biol. Chem. 277 (2002) 15190-15198
44. Dai L., Claxson A., Marklund S.L., Feakins R., Yousaf N., Chernajovsky Y., et al. Amelioration of antigen-induced arthritis in rats by transfer of extracellular superoxide dismutase and catalase genes. Gene Ther. 10 (2003) 550-558
45. Ugur M., Yildirim K., Kiziltunc A., Erdal A., Karatay S., and Senel K. Correlation between soluble intercellular adhesion molecule 1 level and extracellular superoxide dismutase activity in rheumatoid arthritis: a possible association with disease activity. Scand. J. Rheumatol. 33 (2004) 239-243
46. Mazieres B., Masquelier A.M., and Capron M.H. A French controlled multicenter study of intraarticular orgotein versus intraarticular corticosteroids in the treatment of knee osteoarthritis: a one-year followup. J. Rheumatol. 27 Suppl (1991) 134-137
47. Cuzzocrea S., Riley D.P., Caputi A.P., and Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol. Rev. 53 (2001) 135-159
48. Cuzzocrea S., McDonald M.C., Mota-Filipe H., Mazzon E., Costantino G., Britti D., et al. Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis. Arthritis Rheum. 43 (2000) 320-328
49. Muscoli C., Cuzzocrea S., Riley D.P., Zweier J.L., Thiemermann C., Wang Z.Q., et al. On the selectivity of superoxide dismutase mimetics and its importance in pharmacological studies. Br. J. Pharmacol. 140 (2003) 445-460
50. Cuzzocrea S., Mazzon E., di Paola R., Genovese T., Muia C., Caputi A.P., et al. Synergistic interaction between methotrexate and a superoxide dismutase mimetic: pharmacologic and potential clinical significance. Arthritis Rheum. 52 (2005) 3755-3760